Tilray Inc (NASDAQ:TLRY) Shares Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lifted its stake in Tilray Inc (NASDAQ:TLRY) by 9.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 786,874 shares of the company’s stock after buying an additional 71,202 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.08% of Tilray worth $1,042,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TLRY. Barclays PLC grew its holdings in shares of Tilray by 600.4% during the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock worth $359,000 after purchasing an additional 174,997 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Tilray by 32.4% in the third quarter. JPMorgan Chase & Co. now owns 432,031 shares of the company’s stock valued at $760,000 after acquiring an additional 105,803 shares during the period. Pallas Capital Advisors LLC grew its position in shares of Tilray by 59.4% during the fourth quarter. Pallas Capital Advisors LLC now owns 50,438 shares of the company’s stock worth $67,000 after acquiring an additional 18,792 shares during the last quarter. Ameritas Advisory Services LLC acquired a new position in shares of Tilray in the 4th quarter valued at $32,000. Finally, Madrona Financial Services LLC raised its position in Tilray by 40.0% in the 4th quarter. Madrona Financial Services LLC now owns 70,000 shares of the company’s stock valued at $93,000 after purchasing an additional 20,000 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Stock Performance

Shares of TLRY opened at $0.45 on Wednesday. Tilray Inc has a 1 year low of $0.41 and a 1 year high of $2.31. The stock has a market capitalization of $453.33 million, a P/E ratio of -1.50 and a beta of 1.95. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The company’s fifty day moving average is $0.55 and its two-hundred day moving average is $0.99.

Tilray (NASDAQ:TLRY) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The business had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. On average, sell-side analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Piper Sandler dropped their price objective on shares of Tilray from $2.00 to $1.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 9th. Roth Capital reissued a “neutral” rating on shares of Tilray in a report on Monday, April 14th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.